Recruiting studies: Leucogen

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lym
Phase 2 · 8 location(s) · City of Hope Medical Center · NCT06918431 A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Table
Phase 4 · 1 location(s) · Hongxia Wang · NCT07578064 Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents Wi
Phase N/A · 1 location(s) · Aarhus University Hospital · NCT05873322 Pharmacogenomics of Asparaginase Induced Hepatotoxicity
Phase N/A · 2 location(s) · University of Southern California · NCT03568266 Establishment of a Phamacokinetik Model for Erwinase Pharmacokinetiks: The Aim of This Sub Study is to Optimize Target T
Phase N/A · 1 location(s) · Aarhus University Hospital · NCT07499349 Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
Phase 1/Phase 2 · 3 location(s) · St. Jude Children's Research Hospital · NCT04195347 Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refrac
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT07133997 Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
EARLY_Phase 1 · 2 location(s) · Children's Hospital of Orange County · NCT05501899 A Study to Determine Number of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia Asparaginase
Phase N/A · 1 location(s) · Mayo Clinic · NCT06600659 Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombin
Phase 2 · 1 location(s) · University of Washington · NCT06738368 the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07380646

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.